C. Verkindre

727 total citations
13 papers, 545 citations indexed

About

C. Verkindre is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, C. Verkindre has authored 13 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 1 paper in Surgery. Recurrent topics in C. Verkindre's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (3 papers). C. Verkindre is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (3 papers). C. Verkindre collaborates with scholars based in France, United States and United Kingdom. C. Verkindre's co-authors include Charles‐Hugo Marquette, Ramón M. Pujol, A Brichet, J Darras, Jacques Dupont, Alain Wurtz, Tim Overend, François Bart, Gérard Huchon and B. Aguilaniu and has published in prestigious journals such as European Respiratory Journal, Sleep Medicine and Respiratory Medicine.

In The Last Decade

C. Verkindre

13 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Verkindre France 9 478 295 148 137 77 13 545
Roberto Marchese Italy 11 200 0.4× 112 0.4× 34 0.2× 55 0.4× 16 0.2× 18 266
David C. Flenley United Kingdom 6 303 0.6× 138 0.5× 11 0.1× 26 0.2× 20 0.3× 7 372
Elif Kaya Germany 9 65 0.1× 113 0.4× 20 0.1× 56 0.4× 3 0.0× 30 315
Jay Kerecman United States 9 377 0.8× 60 0.2× 2 0.0× 203 1.5× 13 0.2× 13 464
Gültaç Özbay Türkiye 10 41 0.1× 38 0.1× 3 0.0× 43 0.3× 8 0.1× 29 302
Abdulkadir İskender Türkiye 11 43 0.1× 48 0.2× 156 1.1× 194 1.4× 5 0.1× 22 336
Selmin Karataylι-Özgürsoy United States 9 164 0.3× 126 0.4× 36 0.2× 63 0.5× 2 0.0× 16 298
Enrico Monti Italy 6 163 0.3× 28 0.1× 40 0.3× 32 0.2× 22 0.3× 11 237
Manxu Zhao United States 5 69 0.1× 12 0.0× 102 0.7× 125 0.9× 10 0.1× 12 378

Countries citing papers authored by C. Verkindre

Since Specialization
Citations

This map shows the geographic impact of C. Verkindre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Verkindre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Verkindre more than expected).

Fields of papers citing papers by C. Verkindre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Verkindre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Verkindre. The network helps show where C. Verkindre may publish in the future.

Co-authorship network of co-authors of C. Verkindre

This figure shows the co-authorship network connecting the top 25 collaborators of C. Verkindre. A scholar is included among the top collaborators of C. Verkindre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Verkindre. C. Verkindre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gentina, Thibaut, Sébastien Bailly, C. Verkindre, et al.. (2018). Marital quality, partner's engagement and continuous positive airway pressure adherence in obstructive sleep apnea. Sleep Medicine. 55. 56–61. 29 indexed citations
2.
Magnussen, H, C. Verkindre, Damon Jack, et al.. (2010). Indacaterol once-daily is equally effective dosed in the evening or morning in COPD. Respiratory Medicine. 104(12). 1869–1876. 23 indexed citations
3.
Chanez, Pascal, Cécile Contin‐Bordes, Gilles Garcia, et al.. (2010). Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma. Respiratory Medicine. 104(11). 1608–1617. 68 indexed citations
4.
Verkindre, C., et al.. (2010). Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Respiratory Medicine. 104(10). 1482–1489. 59 indexed citations
5.
Vogelmeier, Claus, C. Verkindre, D. Cheung, et al.. (2010). Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Pulmonary Pharmacology & Therapeutics. 23(5). 438–444. 48 indexed citations
6.
Ноников, В Е, C. Verkindre, DB Jack, et al.. (2009). Indacaterol Once-Daily Reduces Days of Poor Control in COPD over 52 Weeks of Treatment.. A6190–A6190. 3 indexed citations
7.
Verkindre, C., et al.. (2005). The Effect of Tiotropium on Hyperinflation and Exercise Capacity in Chronic Obstructive Pulmonary Disease. Respiration. 73(4). 420–427. 78 indexed citations
8.
Verkindre, C., et al.. (2004). L’asthme du sujet âgé. Revue des Maladies Respiratoires. 21(5). 117–125. 2 indexed citations
9.
Verkindre, C., et al.. (2003). [Asthma in the elderly].. PubMed. 20(1 Pt 1). 8S117–103. 4 indexed citations
10.
Brichet, A, C. Verkindre, Jacques Dupont, et al.. (1999). Multidisciplinary approach to management of postintubation tracheal stenoses. European Respiratory Journal. 13(4). 888–888. 189 indexed citations
11.
Verkindre, C., et al.. (1999). Morphological changes induced by extensive endobronchial electrocautery. European Respiratory Journal. 14(4). 796–796. 32 indexed citations
12.
Brichet, A, C. Verkindre, Ramón M. Pujol, & Charles‐Hugo Marquette. (1999). [Post-intubation tracheal stenosis].. PubMed. 16(4 Pt 2). 685–92. 8 indexed citations
13.
Vaylet, F., et al.. (1996). [Acute pulmonary edema induced by vinorelbine].. PubMed. 25(27). 1259–1259. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Marchese Breakdown of academic impact, for papers by David C. Flenley Breakdown of academic impact, for papers by Elif Kaya Breakdown of academic impact, for papers by Jay Kerecman Breakdown of academic impact, for papers by Gültaç Özbay Breakdown of academic impact, for papers by Abdulkadir İskender Breakdown of academic impact, for papers by Selmin Karataylι-Özgürsoy Breakdown of academic impact, for papers by Enrico Monti Breakdown of academic impact, for papers by Manxu Zhao
Rankless by CCL
2026